Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis

Numerous studies have investigated the association of MIR499A rs3746444 polymorphism with breast cancer susceptibility, but the results have been inconsistent. In this work, we performed a meta-analysis to obtain a more reliable estimate of the association between the polymorphism and susceptibility...

Full description

Bibliographic Details
Main Authors: Shing, Cheng Tan, Lim, Poh Ying, Fang, Jie, Mohamad Mokhtar, Mira Farzana, Mohamad Hanif, Ezanee Azlina, Jamal, Rahman
Format: Article
Language:English
Published: Nature Publishing 2020
Online Access:http://psasir.upm.edu.my/id/eprint/87964/1/ABSTRACT.pdf
_version_ 1825952432426844160
author Shing, Cheng Tan
Lim, Poh Ying
Fang, Jie
Mohamad Mokhtar, Mira Farzana
Mohamad Hanif, Ezanee Azlina
Jamal, Rahman
author_facet Shing, Cheng Tan
Lim, Poh Ying
Fang, Jie
Mohamad Mokhtar, Mira Farzana
Mohamad Hanif, Ezanee Azlina
Jamal, Rahman
author_sort Shing, Cheng Tan
collection UPM
description Numerous studies have investigated the association of MIR499A rs3746444 polymorphism with breast cancer susceptibility, but the results have been inconsistent. In this work, we performed a meta-analysis to obtain a more reliable estimate of the association between the polymorphism and susceptibility to breast cancer. A comprehensive literature search was conducted on PubMed, Scopus, Web of Science (WoS), China National Knowledge Infrastructure (CNKI), VIP and Wanfang databases up to January 2020. A total of 14 studies involving 6,797 cases and 8,534 controls were included for analysis under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). A statistically significant association was observed between the polymorphism and an increased breast cancer susceptibility under all genetic models (homozygous, OR = 1.33, 95% CI = 1.03–1.71, P = 0.03; heterozygous, OR = 1.08, 95% CI = 1.00–1.16, P = 0.04; dominant, OR = 1.15, 95% CI = 1.02–1.30; P = 0.03; recessive, OR = 1.35, 95% CI = 1.06–1.72, P = 0.01; allele, OR = 1.12, 95% CI = 1.00–1.26, P = 0.04). Subgroup analysis based on ethnicity suggested that significant association was present only among Asians, but not Caucasians. In conclusion, MIR499A rs3746444 polymorphism was significantly associated with breast cancer susceptibility among Asians, suggesting its potential use as a genetic risk marker in this population.
first_indexed 2024-03-06T10:44:33Z
format Article
id upm.eprints-87964
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T10:44:33Z
publishDate 2020
publisher Nature Publishing
record_format dspace
spelling upm.eprints-879642022-05-24T04:54:19Z http://psasir.upm.edu.my/id/eprint/87964/ Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis Shing, Cheng Tan Lim, Poh Ying Fang, Jie Mohamad Mokhtar, Mira Farzana Mohamad Hanif, Ezanee Azlina Jamal, Rahman Numerous studies have investigated the association of MIR499A rs3746444 polymorphism with breast cancer susceptibility, but the results have been inconsistent. In this work, we performed a meta-analysis to obtain a more reliable estimate of the association between the polymorphism and susceptibility to breast cancer. A comprehensive literature search was conducted on PubMed, Scopus, Web of Science (WoS), China National Knowledge Infrastructure (CNKI), VIP and Wanfang databases up to January 2020. A total of 14 studies involving 6,797 cases and 8,534 controls were included for analysis under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). A statistically significant association was observed between the polymorphism and an increased breast cancer susceptibility under all genetic models (homozygous, OR = 1.33, 95% CI = 1.03–1.71, P = 0.03; heterozygous, OR = 1.08, 95% CI = 1.00–1.16, P = 0.04; dominant, OR = 1.15, 95% CI = 1.02–1.30; P = 0.03; recessive, OR = 1.35, 95% CI = 1.06–1.72, P = 0.01; allele, OR = 1.12, 95% CI = 1.00–1.26, P = 0.04). Subgroup analysis based on ethnicity suggested that significant association was present only among Asians, but not Caucasians. In conclusion, MIR499A rs3746444 polymorphism was significantly associated with breast cancer susceptibility among Asians, suggesting its potential use as a genetic risk marker in this population. Nature Publishing 2020 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/87964/1/ABSTRACT.pdf Shing, Cheng Tan and Lim, Poh Ying and Fang, Jie and Mohamad Mokhtar, Mira Farzana and Mohamad Hanif, Ezanee Azlina and Jamal, Rahman (2020) Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis. Scientific Reports, 10. art. no. 3508. pp. 1-10. ISSN 2045-2322 https://www.nature.com/articles/s41598-020-60442-3#:~:text=In%20conclusion%2C%20MIR499A%20rs3746444%20polymorphism,risk%20marker%20in%20this%20population. 10.1038/s41598-020-60442-3
spellingShingle Shing, Cheng Tan
Lim, Poh Ying
Fang, Jie
Mohamad Mokhtar, Mira Farzana
Mohamad Hanif, Ezanee Azlina
Jamal, Rahman
Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis
title Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis
title_full Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis
title_fullStr Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis
title_full_unstemmed Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis
title_short Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis
title_sort association between mir499a rs3746444 polymorphism and breast cancer susceptibility a meta analysis
url http://psasir.upm.edu.my/id/eprint/87964/1/ABSTRACT.pdf
work_keys_str_mv AT shingchengtan associationbetweenmir499ars3746444polymorphismandbreastcancersusceptibilityametaanalysis
AT limpohying associationbetweenmir499ars3746444polymorphismandbreastcancersusceptibilityametaanalysis
AT fangjie associationbetweenmir499ars3746444polymorphismandbreastcancersusceptibilityametaanalysis
AT mohamadmokhtarmirafarzana associationbetweenmir499ars3746444polymorphismandbreastcancersusceptibilityametaanalysis
AT mohamadhanifezaneeazlina associationbetweenmir499ars3746444polymorphismandbreastcancersusceptibilityametaanalysis
AT jamalrahman associationbetweenmir499ars3746444polymorphismandbreastcancersusceptibilityametaanalysis